Company Profile

Olfa Thera Inc
Profile last edited on: 3/21/2023      CAGE: 94PU1      UEI: C8PGYYTCSAR4

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2021
First Award
2022
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

550 18th Street Apt 404
San Francisco, CA 94107
   (781) 521-2377
   N/A
   N/A
Location: Single
Congr. District: 11
County: San Francisco

Public Profile

The principals of Olfa Thera seek to create a small molecule therapeutic to reverse opioid induced respiratory depression by stimulating breathing through an ectopic olfactory receptor pathway that is independent from opioid receptors

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 1 NIH $320,000
Project Title: Targeting a non-opioid signaling pathway to reverse opioid-induced respiratory depression

Key People / Management

  Alexandra Scharr

Company News

There are no news available.